id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-346656-5nz0bs4v	Masini, Francesco	Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic	2020-07-14		.txt	text/plain	670	36	40	Usually, discontinuing therapeutic treatment is not recommended, since clinical flares of rheumatic disease develop with subsequent use of other immunosuppressants such as corticosteroids, equally unsafe in the case of COVID-19 occurrence [3] . The European League Against Rheumatism (EULAR) and the Italian Society of Rheumatology (SIR) clinical guidance during COVID-19 pandemic recommended management of patients on long-term corticosteroid therapy by gradually tapering doses, and warning against abrupt cessation of corticosteroid therapy, even during active infection. SIR has also promoted a dedicated platform, "CONTROL-19", for the remote monitoring of COVID-19 impact on rheumatic diseases [6] . Although more evidence is required to demonstrate the real impact of this strategy, telemedicine has demonstrated as a valid alternative to improve the quality of rheumatic patients' care during COVID-19 pandemic, thus reducing hospitalizations only to urgent admissions. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy SIR (2020) COVID-19 monitoring in patients with rheumatic and musculoskeletal diseases	./cache/cord-346656-5nz0bs4v.txt	./txt/cord-346656-5nz0bs4v.txt